Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination of homeopathic vaccines, or nosodes, was evaluated in a randomized controlled trial led by Dr. Mark Loeb at McMaster University (NCT02825368). The preparation includes Diphtherinum, Pertussinum, Tetanotxicum, Morbilinum, and Ourlianum, which are highly diluted (30cH, 200cH, and 1000cH) substances derived from the causative agents or products of diphtheria, pertussis, tetanus, measles, and mumps, respectively. The study aimed to compare the immunological response of these nosodes against conventional vaccines (Tdap and MMR) and placebo in healthy young adults. Results published in 2018 demonstrated that the homeopathic preparations failed to produce any detectable antibody response, yielding results indistinguishable from the placebo group, whereas conventional vaccines produced robust immunity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Diphtherinum + Pertussinum + Tetanotxicum + Morbilinum + Ourlianum.